VAERS reports by lot

Pfizer COVID-19 lot HJ7224: VAERS reports

20 VAERS reports list lot HJ7224 as a Pfizer COVID-19 vaccine, received between 2023-11-30 and 2024-10-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological919%
Respiratory613%
Musculoskeletal613%
Dermatological (non-injection-site)613%
General / Systemic (non-local)613%
Injection-site / Local reaction511%
Allergic / Anaphylactic49%
Cardiac / Cardiovascular24%
Gastrointestinal24%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan3
Iowa2
Washington2
Delaware1
Louisiana1
Ohio1
Missouri1
Alabama1
New Jersey1
Tennessee1
New York1
North Carolina1

Reports by month received

2023-111
2023-122
2024-015
2024-025
2024-032
2024-043
2024-051
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.